Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 11, 2026.
Not yet recruitingNCT07922824
Retinal Arterial Macroaneurysm
Observational18 years - Not specifiedLocation not listed Retinal arterial macroaneurysm (RAM) is an acquired dilatation of a retinal arteriole that can rupture or leak, causing hemorrhage, exudation, macular edema, and vision loss. No standardized treatment exists, and options range from observation to las…
RecruitingNCT05436418
Peripheral Blood Stem Cell Transplantation · Hematopoietic Stem Cell Transplantation
Phase 1 / Phase 212 years - 120 yearsDuarte, California, United States +1 Background: Blood cancers (such as leukemias or lymphomas) often do not respond to standard treatments. A transplant of blood stem cells from a healthy donor can help people with these cancers. Sometimes these transplants cause serious side effects, …
CompletedNCT04462159
Atherosclerotic Cardiovascular Disease · Coronary Artery Disease
Not applicable18 years - 59 yearsNew York, New York, United States The purpose of our project is to better understand the characteristics of the young patients with coronary artery disease presenting for cardiac catheterization at our institution and to put forth a program to optimize their risk factors with a focus…
RecruitingNCT07284459
Idiopathic Pulmonary Fibrosis
Phase 240 years - Not specifiedMar del Plata, Buenos Aires, Argentina +98 This is a Ph 2, randomized, double-blind, placebo-controlled global multicenter study to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of PIPE-791 in participants with a diagnosis of Idiopathic Pulmonary Fibrosis (IPF) with o…
RecruitingNCT07914920
Post-induction Hypotension (PIH) · Postprandial Hypotension · Frailty
Observational65 years - Not specifiedKonya, Konya, Turkey (Türkiye) The goal of this observational study is to learn whether a drop in blood pressure after a meal (postprandial hypotension) and frailty are linked to low blood pressure after the start of general anesthesia (post-induction hypotension) in adults aged 6…
CompletedNCT04530123
Celiac Disease
Phase 218 years - 75 yearsScottsdale, Arizona, United States +41 The main aim of the study is to assess if TAK-101 can reduce gluten related symptoms and immune activation in adult participants with celiac disease (CeD) on a gluten-free diet (GFD). Participants will receive TAK-101 and/or placebo through the vein …
RecruitingNCT06918561
Open Wound
Not applicable18 years - Not specifiedDenham Springs, Louisiana, United States +14 This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating chronic open wounds.
RecruitingNCT07739966
Solid Tumor · Locally Advanced Non-Small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer
Phase 1 / Phase 218 years - Not specifiedFayetteville, Arkansas, United States +67 The primary purpose of the study is to evaluate the safety, tolerability, and efficacy of DS-3939a in combination with other anticancer agents or as a monotherapy in participants with solid tumors.
RecruitingNCT07796061
DMG · DIPG
Phase 13 years - 25 yearsWashington D.C., District of Columbia, United States This is an open-label phase 1 safety and feasibility study evaluating a novel combination therapy for Diffuse Midline Glioma (DMG), an aggressive brain tumor with a very poor prognosis - an average one-year overall survival. This study combines blood…
RecruitingNCT07076342
Major Depressive Disorder (MDD)
Phase 418 years - Not specifiedStony Brook, New York, United States This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a common pathway in improving sleep and depression.
RecruitingNCT06340568
Endometrial Cancer
Phase 318 years - Not specifiedLos Angeles, California, United States +173 The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth factor receptor 2 (HER2) in their tumor sample. In Cohort 1, the main goal is to assess how well BNT32…
RecruitingNCT07020221
Pancreatic Ductal Adenocarcinoma · Non Small Cell Lung Cancer · Colorectal Cancer · Solid Tumor, Adult · G12D Mutated KRAS
Phase 1 / Phase 218 years - Not specifiedLos Angeles, California, United States +20 This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G12D-mutation.
Retrieved from ClinicalTrials.gov: Nov 11, 2026. Overall study status may differ from a particular location’s status.
